David Clark
Director of Finance/CFO en OBLONG, INC. .
Fortuna: 444 $ al 31/03/2024
Perfil
David C.
Clark is currently the Chief Financial Officer, Secretary & Treasurer at Oblong, Inc. He previously held the same position at Glowpoint, Inc. Additionally, he served as Treasurer, VP-Finance & Assistant Secretary at Allos Therapeutics, Inc. from 2004 to 2012.
Prior to that, he worked as an Audit Manager at PricewaterhouseCoopers LLP from 1992 to 2000.
From 2000 to 2003, he was the Chief Financial Officer & Vice President at Seurat Co. He also held the position of Chief Financial Officer, Secretary & Treasurer at Affinity VideoNet, Inc. Mr. Clark completed his undergraduate and graduate degrees at the University of Denver.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
OBLONG, INC.
0.02% | 08/03/2024 | 3 262 ( 0.02% ) | 444 $ | 31/03/2024 |
Cargos activos de David Clark
Empresas | Cargo | Inicio |
---|---|---|
OBLONG, INC. | Director of Finance/CFO | 01/03/2013 |
Antiguos cargos conocidos de David Clark.
Empresas | Cargo | Fin |
---|---|---|
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Director of Finance/CFO | 05/09/2012 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01/01/2000 |
OBLONG INC. | Director of Finance/CFO | - |
Formación de David Clark.
University of Denver | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
OBLONG, INC. | Electronic Technology |
Empresas privadas | 3 |
---|---|
Glowpoint, Inc.
Glowpoint, Inc. Specialty TelecommunicationsCommunications Glowpoint, Inc. engages in the provision of video collaboration and network applications. Its products and services include the following: Tier One Help Desk Support; Resolve Fully Outsourced Support; Notify; Knowledge Based Training Programs; Managed Video Conferencing Services; JoinMyVideo Cloud Conferencing Services; Video Conferencing Suites; Webcasting and Streaming and Network Services. The company was founded in May 2000 and is headquartered in Denver, CO. | Communications |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
- Bolsa de valores
- Insiders
- David Clark